Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression

Oncogene

Volumn 22, Issue 22, 2003, Pages 3407-3411

  Wilhelmsson, Ulrika ^a   Eliasson, Camilla ^a   Bjerkvig, Rolf ^b   Pekny, Milos ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Astrocytoma; Gene targeting; Glial fibrillary acidic protein; Intermediate filaments; p53

Indexed keywords

ETHYLNITROSOUREA; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN P53;

ANAPLASTIC CARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOMA; CANCER GRADING; CANCER GROWTH; CONTROLLED STUDY; DRUG EXPOSURE; GENE EXPRESSION; GENE LOSS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ASTROCYTOMA; BRAIN NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; ETHYLNITROSOUREA; GLIAL FIBRILLARY ACIDIC PROTEIN; MICE; RATS; RATS, NUDE;

ANIMALIA;

EID: 0037780759     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206372     Document Type: Article

References (39)

1. Bigner SH, McLendon RE, Al-dosari N and Rasheed A. (1998). The Genetic Basis of Human Cancer. Vogelstein B and Kinsler KW (eds). McGraw-Hill: New York, pp. 661-670.
2. Chen WJ and Liem RK. (1994). J. Cell Biol., 127, 813-823.
3. Dalton S. (1992). EMBO J., 11, 1797-1804.
4. Deck JH, Eng LF, Bigbee J and Woodcock SM. (1978). Acta Neuropathol. (Berl.), 42, 183-190.
5. Eliasson C, Sahlgren C, Berthold CH, Stakeberg J, Celis JE, Betsholtz C, Eriksson JE and Pekny M. (1999). J. Biol. Chem., 274, 3996-4006.
6. Eng LF, Vanderhaeghen JJ, Bignami A and Gerstl G. (1971). Brain Res., 28, 351-354.
7. Eng LF and Rubinstein LJ. (1978). J. Histochem. Cytochem., 26, 513-522.
8. Eng LF, Ghirnikar RS and Lee YL. (2000). Neurochem. Res., 25, 1439-1451.
9. Engebraaten O, Hjortland GO, Hirschberg H and Fodstad O. (1999). J. Neurosurg., 90, 125-132.
10. Hara A, Sakai N, Yamada H, Niikawa S, Ohno T, Tanaka T and Mori H. (1991). Surg. Neurol., 36, 190-194.
11. Inagaki M, Gonda Y, Nishizawa K, Kitamura S, Sato C, Ando S, Tanabe K, Kikuchi K, Tsuiki S and Nishi Y. (1990). J. Biol. Chem., 265, 4722-4729.
12. Jacque CM, Vinner C, Kujas M, Raoul M, Racadot J and Baumann NA. (1978). J. Neurol. Sci., 35, 147-155.
13. Jacque CM, Kujas M, Poreau A, Raoul M, Collier P, Racadot J and Baumann N. (1979). J. Natl. Cancer Inst., 62, 479-483.
14. Kajiwara K, Orita T, Nishizaki T, Kamiryo T, Nakayama H and Ito H. (1992). Brain Res., 572, 314-318.
15. Ku NO, Liao J, Chou CF and Omary MB. (1996). Cancer Metastasis Rev., 15, 429-444.
16. Leonard JR, D'Sa C, Klocke BJ and Roth KA. (2001). Oncogene, 20, 8281-8286.
17. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD. (1992). Cell, 70, 923-935.
18. Oda H, Zhang S, Tsurutani N, Shimizu S, Nakatsuru Y, Aizawa S and Ishikawa T. (1997). Cancer Res., 57, 646-650.
19. Pekny M, Levéen P, Pekna M, Eliasson C, Berthold C-H, Westermark B and Betsholtz C. (1995). EMBO J., 14, 1590-1598.
20. Pekny M, Eliasson C, Chien CL, Kindblom LG, Liem R, Hamberger A and Betsholtz C. (1998). Exp. Cell Res., 239, 332-343.
21. Pekny M, Johansson CB, Eliasson C, Stakeberg J, Wallen A, Perlmann T, Lendahl U, Betsholtz C, Berthold CH and Frisen J. (1999). J. Cell Biol., 145, 503-514.
22. Pekny M. (2001). Prog. Brain Res., 132, 23-30.
23. Rutka JT and Smith SL. (1993). Cancer Res., 53, 3624-3631.
24. Rutka JT, Hubbard SL, Fukuyama K, Matsuzawa K, Dirks PB and Becker LE. (1994). Cancer Res., 54, 3267-3272.
25. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W and Vogelstein B. (1992). Nature, 355, 846-847.
26. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH and Tavtigian SV. (1997). Nat. Genet., 15, 356-362.
27. Tascos NA, Parr J and Gonatas NK. (1982). Hum. Pathol., 13, 454-458.
28. Toda M, Miura M, Asou H, Toya S and Uyemura K. (1994). J. Neurochem., 63, 1975-1978.
29. Toda M, Miura M, Asou H, Sugiyama I, Kawase T and Uyemura K. (1999). Neurochem. Res., 24, 339-343.
30. Tsujimura K, Tanaka J, Ando S, Matsuoka Y, Kusubata M, Sugiura H, Yamauchi T and Inagaki M. (1994). J. Biochem. (Tokyo), 116, 426-434.
31. van der Meulen JD, Houthoff HJ and Ebels EJ. (1978). Neuropathol. Appl. Neurobiol., 4, 177-190.
32. Velasco ME, Dahl D, Roessmann U and Gambetti P. (1980). Cancer, 45, 484-494.
33. Wechsler W, Rice JM and Vesselinovitch SD. (1979). Natl. Cancer Inst. Monogr., 51, 219-226.
34. Weinstein DE, Shelanski ML and Liem RK. (1991). J. Cell. Biol., 112, 1205-1213.
35. Weiss WA. (2000). Curr. Opin. Pediatr., 6, 543-548.
36. Westermark B. (1973). Int. J. Cancer, 12, 438-451.
37. Yahanda AM, Bruner JM, Donehower LA and Morrison RS. (1995). Mol. Cell. Biol., 15, 4249-4259.
38. Yong VW. (1992). J. Neurol. Sci., 111, 92-103.
39. Zhu Y and Parada LF. (2002). Nat. Rev. Cancer, 8, 616-626.